[Form 4] Streamline Health Solutions, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Wyche T. Green III, Executive Chairman and Director of Streamline Health Solutions, reported disposals of company securities on 08/12/2025 pursuant to a merger. The Form 4 states the Merger Agreement dated May 29, 2025 became effective August 12, 2025, and each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share. The report shows dispositions and post-transaction beneficial ownership figures, and notes that certain restricted stock awards (11,199 shares) were converted into cash equal to their share count times the $5.34 Merger Consideration, less taxes.

The filing also reports treatment of outstanding warrants: Company warrants were canceled and either converted into a cash payment when the warrant exercise price was less than the $5.34 Merger Consideration or canceled for no consideration when the exercise price was equal to or greater than $5.34. The Form shows securities held in the account of 121G, LLC, which may be deemed beneficially owned by Mr. Green, and notes a 1-for-15 reverse split adjustment on October 4, 2024.

Positive

• Merger completed with clear cash consideration: Each outstanding common share was converted into the right to receive $5.34 per share in cash.
• Restricted awards addressed: The filing explicitly converts 11,199 restricted shares into cash equal to their share count times the $5.34 Merger Consideration, less taxes.
• Warrant treatment defined: The Form explains that warrants with exercise prices below the Merger Consideration convert to a cash payment formula, clarifying derivative settlement.

Negative

• Some warrants may be canceled for no consideration: The filing states any company warrant with an exercise price equal to or greater than the $5.34 Merger Consideration was canceled for no consideration.
• Insider loses direct equity stake: Reported dispositions tied to the merger indicate the reporting person’s outstanding shares and certain derivative positions were surrendered for cash.

Insights

Financial Analyst

TL;DR: Executive Chairman disposed shares and warrants in a cash merger paying $5.34 per common share; restricted awards converted to cash.

The Form 4 documents a corporate acquisition effective 08/12/2025 under a Merger Agreement dated 05/29/2025 whereby each outstanding common share was canceled for $5.34 in cash. Reported figures include 79,437 and 69,845 common shares shown in Table I and 59,829 warrant-related underlying shares in Table II; 11,199 restricted shares are specifically noted as converted to cash. The filing confirms mechanics for warrant treatment and that some securities are held via 121G, LLC, indicating indirect beneficial ownership. For investors, this is a material liquidity event that settles equity and many derivative claims in cash.

Corporate Governance Expert

TL;DR: Disclosure is routine and complete for a Section 16 report tied to a merger; indirect ownership and reverse split are properly noted.

The Form 4 identifies the reporting person, corporate role (Executive Chairman and Director), transaction date (08/12/2025), and the Merger Agreement reference. It includes required explanatory footnotes: conversion of restricted stock awards, holding via 121G, LLC, a 1-for-15 reverse split adjustment (10/04/2024), and detailed warrant treatment. The filing appears to meet Section 16(a) disclosure requirements by reporting dispositions and the post-transaction beneficial ownership figures and by providing signatures. No additional governance irregularities are disclosed in the document text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Wyche T III

(Last) (First) (Middle)

2400 OLD MILTON PARKWAY

BOX 1353

(Street)

ALPHARETTA GA 30009

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.01 par value	08/12/2025		D(1)		79,437(2)	D	(1)(2)	0	D
Common Stock, $0.01 par value	08/12/2025		D(1)		69,845	D	(1)	0	I	Refer to footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (right to buy)	$5.85(4)	08/12/2025		D(1)			59,829	(5)	(5)	Common Stock, $0.01 par value	59,829	(5)	0	I	Refer to footnote(3)

Explanation of Responses:

1. This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration").

2. Includes 11,199 shares of restricted stock. Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock award corresponding to shares of Common Stock that was outstanding and unvested as of immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Common Stock corresponding to such award of restricted stock immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.

3. The securities are held in the account of 121G, LLC (the "Holder") and may be deemed to be beneficially owned by Wyche "Tee" Green, III, the managing member of the holder.

4. The Issuer effected a 1-for-15 reverse stock split of its common stock on October 4, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split.

5. Pursuant to the terms of the Merger Agreement, at the Effective Time, each warrant to purchase shares of Common Stock (each, a "Company Warrant") that was outstanding and unexercised and had a per share exercise price that was less than the Merger Consideration was canceled and converted into the right to receive (i) a cash payment equal to (A) the number of shares of Common Stock subject to the Company Warrant immediately prior to the Effective Time multiplied by (B) the excess, if any, of (x) the Merger Consideration over (y) the exercise price per share of Common Stock of such Company Warrant, less applicable withholding taxes. Each Company Warrant that was outstanding and unexercised with a per share exercise price that was equal to or greater than the Merger Consideration was canceled for no consideration.

	/s/ Wyche T. Green, III	08/14/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Streamline Health (STRM) insiders receive for each share in the merger?

The Form 4 states that each outstanding share of common stock was converted into the right to receive $5.34 in cash per share at the Effective Time.

When did the merger that triggered the Form 4 become effective for STRM?

The Form 4 identifies the Effective Time of the Merger as 08/12/2025 and references the Merger Agreement dated 05/29/2025.

How many restricted shares were converted to cash for Wyche T. Green III?

The filing explicitly states that the reporting amounts include 11,199 shares of restricted stock, which were converted into cash based on the Merger Consideration.

What happened to Streamline Health warrants in the merger?

The Form explains that Company warrants with exercise prices less than $5.34 were converted into a cash payment equal to the excess of $5.34 over the exercise price times the number of shares; warrants with exercise prices equal to or greater than $5.34 were canceled for no consideration.

Are the reported securities directly owned by Wyche T. Green III?

The filing notes some securities are held in the account of 121G, LLC, which may be deemed beneficially owned by Wyche T. Green, III as the managing member, indicating indirect ownership.